Clearside Financial Statements From 2010 to 2026
| CLSDDelisted Stock | USD 0.41 0.16 28.07% |
Check Clearside Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clearside Biomedical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Clearside financial statements analysis is a perfect complement when working with Clearside Biomedical Valuation or Volatility modules.
Clearside |
Clearside Biomedical Company Current Valuation Analysis
Clearside Biomedical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Clearside Biomedical Current Valuation | (2.33 M) |
Most of Clearside Biomedical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Clearside Biomedical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Clearside Biomedical has a Current Valuation of (2.33 Million). This is 100.02% lower than that of the Pharmaceuticals sector and 100.05% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.01% higher than that of the company.
Clearside Biomedical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Clearside Biomedical's current stock value. Our valuation model uses many indicators to compare Clearside Biomedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Clearside Biomedical competition to find correlations between indicators driving Clearside Biomedical's intrinsic value. More Info.Clearside Biomedical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Clearside Biomedical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Clearside Biomedical Financial Statements
Clearside Biomedical stakeholders use historical fundamental indicators, such as Clearside Biomedical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Clearside Biomedical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Clearside Biomedical's assets and liabilities are reflected in the revenues and expenses on Clearside Biomedical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Clearside Biomedical. Please read more on our technical analysis and fundamental analysis pages.
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia. Clearside Biomedi operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Clearside Stock
If you are still planning to invest in Clearside Biomedical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Clearside Biomedical's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |